Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Myeloid 1Gynecologic 1Gastrointestinal 1Endocrine 1CNS 1

Conditions

Hepatoblastoma 5Sarcoma 4Carcinoma, Hepatocellular 4Stomach Neoplasms 3Rhabdoid Tumor 3Neuroectodermal Tumors, Primitive, Peripheral 3Medulloblastoma 3Central Nervous System Neoplasms 3Wilms Tumor 2Retinoblastoma 2Rectal Neoplasms 2Pancreatic Neoplasms 2Optic Nerve Glioma 2Liver Neoplasms 2Gastro-enteropancreatic neuroendocrine tumor 2Familial ependymoma 2Colonic Neoplasms 2Carcinoma, Renal Cell 2Astrocytoma 2Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma 1Rhabdomyosarcoma 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Osteosarcoma 1Oligodendroglioma 1Neuroendocrine Tumors 1Neuroblastoma 1Neoplasms, Germ Cell and Embryonal 1

Interventions

Gemcitabine 11pembrolizumab 10Oxaliplatin 7Nivolumab 7Irinotecan 7Fluorouracil 7Capecitabine 7durvalumab 6Sorafenib 6Leucovorin 6Cyclophosphamide 6Paclitaxel 5Ipilimumab 5tislelizumab 3poly ICLC 3lenvatinib 3fludarabine 3Sunitinib 3Radiotherapy 3Cisplatin 3Cetuximab 3130-nm albumin-bound paclitaxel 3seocalcitol 2selinexor 2pemigatinib 2futuximab 2fludarabine phosphate 2donafenib 2cemiplimab 2atezolizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma × Etoposide × Gastrointestinal × Clear all
NCT06813079 2025-02-18

Using Tumor Models to Determine Treatments

University Health Network, Toronto

Phase 2 Not yet recruiting
25 enrolled
Gastrointestinal

Carcinoma, Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡